• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Role of cytochrome P450 dependent elcosanoids in progressive renal diseases and hypertension

Research Project

Project/Area Number 12671018
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeSingle-year Grants
Section一般
Research Field Kidney internal medicine
Research InstitutionMiyagi University of Education

Principal Investigator

OMATA Ken  Miyagi University of Education, Health Administration Center, Director, 保健管理センター, 教授 (50194634)

Co-Investigator(Kenkyū-buntansha) ITO Sadayoshi  Tohoku University School of Medicine, The Second Department ofInteraal Medicine, Professor, 大学院・医学系研究科, 教授 (40271613)
Project Period (FY) 2000 – 2002
Project Status Completed (Fiscal Year 2002)
Budget Amount *help
¥3,300,000 (Direct Cost: ¥3,300,000)
Fiscal Year 2002: ¥500,000 (Direct Cost: ¥500,000)
Fiscal Year 2001: ¥1,200,000 (Direct Cost: ¥1,200,000)
Fiscal Year 2000: ¥1,600,000 (Direct Cost: ¥1,600,000)
Keywordscytochrome P450 / arachidonic acid / 20-HETE / EET / SHR / androgen / hypertension / progressive renal disease / アンジオテンシン / ACE阻害薬 / アンジオテンシン受容体拮抗薬
Research Abstract

The kidney plays a key role in the development and the maintenance of hypertension. We studied the pathophysiological role of renal vasoactive substances. Renin-angiotensin, kallikrein-kinin, prostaglandins and cytochrome P450 systems are localized to specific nephron segments, suggesting the intimate relationship between these substances and the nephron segments in which that localized. There were marked age-dependent changes in the production rate of these substances. The changes are also dependent on the maturation and the differentiation of the nephron. Furthermore, there were significant changes of production rates of these substances in the animal model of hypertension, such as spontaneously hypertensive rats and Dahl salt sensitive rats. The production rate of vasodepressoi substances, such as kallikrein-kinin and prostaglandins systems decreased in hypertensive subjects. On the contrary, the production rate of 19-hydroxyeicosatetraenoic acid (HETE) and 20-HETE which synthesized by renal cytochrome P450, the third metabolic pathway of arachidonic acid increased in hypertensive subjects. 19-HETE stimulates Na-K-ATPase and 20-HETE constricts the vasculature, suggesting the basopressor roles of these substances. In addition, prostacyclin synthesized by cyclooxygenase inhibits and epoxyeicosatrienoic acids synthesized by cytochrome P450 stimulate the cell growth of vascular smooth muscle cells and glomerular mesangial cells in culture. When arachidonic acid is synthesized by cyclooxygenase, the cell growth is inhibited and when arachidonate is synthesize by cytochiome P450, the cell growth is stimulated. Furthermore, androgen stimulates P450 4A protein and 20-HETE production in SHR, In hypertensive subjects prostacyclm, the cyclooxygenase products is decreased and cytochrome P450 activity is increased. These results suggest that these vasoactive substances have the role of the development of renal damage as well as the vascular damage in hypertensive subjects.

Report

(4 results)
  • 2002 Annual Research Report   Final Research Report Summary
  • 2001 Annual Research Report
  • 2000 Annual Research Report
  • Research Products

    (18 results)

All Other

All Publications (18 results)

  • [Publications] Ito O et al.: "Effects of converting enzyme inhibitors on renal P-450 metabolism of arachidonic acid"Am.J.Physiol.. 280. R822-R830 (2000)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2002 Final Research Report Summary
  • [Publications] Kohagura K et al.: "Involvement of cytochrome P450 metabolites in the vascular action of angiotensin II on the afferent arterioles"Hypertens Res.. 24. 551-557 (2001)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2002 Final Research Report Summary
  • [Publications] Arima S et al.: "Biphasic vasodilator action of troglitazone on the renal microcirculation"J Am Soc Nephrol. 13. 342-349 (2002)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2002 Final Research Report Summary
  • [Publications] Ito O. et al.: "Effects of converting enzyme inhibitors on renal P450 metabolism of arachidonic acid"Am.J.Physiol.. 280. R822-R830 (2000)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2002 Final Research Report Summary
  • [Publications] Kohagura K et al.: "Involvement of cytochrome P450 metabolites in the vascular action of angiotensin II on the afferent arterioles"Hypertens Res.. 24. 551-557 (2001)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2002 Final Research Report Summary
  • [Publications] Arima S et al.: "Biphasic vasodilator action of troglitazone on the renal microcirculation"J Am Soc Nephrol.. 13. 342-439 (2002)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2002 Final Research Report Summary
  • [Publications] Ito O.et al.: "Effects of converting enzyme inhibiors on renal P450 metabolism of arachidonic acid"Am. J. Physiol.. 280. R822-R830 (2000)

    • Related Report
      2002 Annual Research Report
  • [Publications] Kohagura K et al.: "Involvenent of cytochromeP450 metabolites in the vascular action of angioteusin II on the afferent arterioles"Hypertens Res.. 24. 551-557 (2001)

    • Related Report
      2002 Annual Research Report
  • [Publications] Arima S ce al.: "Biphasic vasodilator action of troglitazane on the renal microcirculaion"J Am Soc Nephrol.. 13. 342-349 (2002)

    • Related Report
      2002 Annual Research Report
  • [Publications] Ito O. et al.: "Effects of converting enzyme inhibitors on renal P450 metabolism of arachidonic acid"Am. J. Physiol. 280. R882-R830 (2000)

    • Related Report
      2001 Annual Research Report
  • [Publications] Kohagura K et al.: "Involvement of cytochrome P450 metabolites in the vascular action of angiotensin II on the afferent arterioles"Hypertens Res.. 24. 551-557 (2001)

    • Related Report
      2001 Annual Research Report
  • [Publications] Arima S et al.: "Biphasic vasodilator action of troglitazone on the renal microcirculation"J Am Soc Naphrol. 13. 342-349 (2002)

    • Related Report
      2001 Annual Research Report
  • [Publications] Omata K et al.: "Therapeutic advantage of angiotensinconverting enzyme inhibitors in chronic renal diseases."Kidney Int.. 49 (Suppl 55). S57-S62 (1996)

    • Related Report
      2000 Annual Research Report
  • [Publications] Arima S et al.: "Diverse effects of calcium antagonists on glomerular hemodynamics."Kidney Int.. 49 (Suppl 55). S132-S134 (1996)

    • Related Report
      2000 Annual Research Report
  • [Publications] Ito O et al.: "Tyrosine kinase, phosphatidylinositol 3-kinase, and protein kinase C regulate insulin-stimulated NaCl transport in the thick ascending limb."Kidney Int.. 51. 1037-1041 (1997)

    • Related Report
      2000 Annual Research Report
  • [Publications] Arima S et. al.: "Possible role of P450 metabolite of arachidonic acid in vasodilator mechanism of angiotensin II type 2 receptor in the isolated microperfused rabbit afferent arteriole."J Clin Invest.. 100. 2816-2823 (1997)

    • Related Report
      2000 Annual Research Report
  • [Publications] Endo Y et al.: "Vasodilation mediated by angiotensin II type 2 receptor is impaired in afferent arterioles of young spontaneously hypertensive rats."J Vas Res.. 35. 421-427 (1998)

    • Related Report
      2000 Annual Research Report
  • [Publications] Ito O. et al.: "Effects of converting enzyme inhibitors on renal P450 metabolism of arachidonic acid."Am.J.Physiol.. 280. R822-R830 (2000)

    • Related Report
      2000 Annual Research Report

URL: 

Published: 2000-04-01   Modified: 2016-04-21  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi